76
Participants
Start Date
September 30, 2009
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Omega-3
Subjects meeting eligibility criteria will be randomized to receive a supply of omega-3-acid ethyl esters or placebo, and instructed to take 4 capsules daily. A 3-month supply of study drug will be given following randomization and at 3, 6, and 9 months. Subjects will be asked to bring unused supplies to each quarterly visit for ascertainment of adherence.
Placebo
Denver Health and Hospital Authority, Denver
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
GlaxoSmithKline
INDUSTRY
Denver Health and Hospital Authority
OTHER